EOI: Study of Modifications of Beta Cell Antigens in the Immunopathogenesis and Treatment of Type 1 Diabetes

Agency: 
JDRF

Expressions of interest are sought from investigators interested in elucidating the existence of and potential role for beta cell antigen modifications in type 1 diabetes immunopathogenesis. The translational potential of the investigations should be highlighted and thus, research plans involving human samples should be emphasized and will be given priority. This initiative encourages collaborations between experts in the fields of T1D, biochemistry, proteomics and other autoimmune diseases. We also welcome investigators with assays or hypotheses relevant to this initiative.

Deadline: 
September 9, 2011

Last updated August 01, 2011